1 Min Read
May 24 (Reuters) - PIXIUM VISION SA:
* PIXIUM VISION ADVANCES IN REVIEW BY THE FRENCH HEALTH AUTHORITY FOR ELIGIBILITY OF IRIS®II REIMBURSEMENT UNDER FORFAIT INNOVATION Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.